Fluoroscopy devices are essential medical imaging equipment that provide real-time moving X-ray images for medical diagnosis and interventional procedures. They are commonly used in cardiovascular procedures, gastroenterology procedures, urology procedures, and orthopedic procedures. Fluoroscopy devices offer advantages such as high image quality, portability, cheaper cost of ownership compared to other medical imaging modalities like CT and MRI scanners. The growing prevalence of chronic diseases and rising demand for minimally invasive surgeries are expected to drive the demand for fluoroscopy across hospitals and specialty clinics in the coming years.
The global Fluoroscopy Devices Market is estimated to be valued at US$ 5437.8 Mn in 2024 and is expected to exhibit a CAGR of 4.2% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
The increasing adoption of fluoroscopy guided procedures is one of the key trends driving the growth of the fluoroscopy devices market. Traditionally, open surgeries were the standard procedures for many conditions. However, minimally invasive surgeries assisted by fluoroscopy guidance are gaining popularity as they offer advantages like reduced post-surgical trauma, negligible scarring, shorter hospital stay, and quicker recovery time. From cardiovascular interventions to urology procedures, fluoroscopy is increasingly being utilized to perform diverse procedures accurately and safely. This has significantly boosted the demand for fluoroscopy devices across modern healthcare settings over the past few years. The development of advanced imaging features like low radiation dose imaging in new device models by leading manufacturers is further expected to encourage wider acceptance of fluoroscopy procedures.
Segment Analysis
The global fluoroscopy devices market is dominated by the fluoroscopy c-arms sub segment. C-arms accounted for over 60% of the overall fluoroscopy device market in 2024 as they are frequently used in cardiological, urological, gastrointestinal and orthopedic procedures. C-arms provide real-time imaging and easy maneuverability which has made them the preferred choice among doctors for minimally invasive surgeries.
Key Takeaways
The Global Fluoroscopy Devices Market Demand is expected to witness high growth over the forecast period of 2024 to 2031. The global Fluoroscopy Devices Market is estimated to be valued at US$ 5437.8 Mn in 2024 and is expected to exhibit a CAGR of 4.2% over the forecast period 2024 to 2031.
Regional analysis shows that North America accounted for over 35% market share in 2024 and is expected to maintain its dominance during the forecast period. Factors such as rising prevalence of chronic diseases, increasing healthcare expenditures and widespread health insurance coverage are driving the market in the region. Europe was the second largest market and is expected to grow at a CAGR of 4% during the forecast period.
Key players operating in the fluoroscopy devices market are Kemira Oyj, ION EXCHANGE (I) Ltd, Thermax Ltd, BASF-SE, GE Water & Process Technologies, Dorf Ketal, Chembond India Ltd, SNF Group, Vasu Chemicals, and E. I. du Pont de Nemours and Company, Shandong Taihe Water Treatment Technologies Co., Ltd., and Shandong XinTai Water Treatment Technology Co., Ltd. GE Healthcare dominates the fluoroscopy devices market with over 20% market share in 2024 owing to its wide portfolio of C-arms and angiography systems. Philips Healthcare holds the second position and focuses on strengthening its position in low and middle income countries.
Explore more information on this topic, Please visit-
https://www.marketwebjournal.com/fluoroscopy-devices-market-and-trnds-analysis-share-size-demand-forecast/
Comments
0 comment